Need to chat, call us on 1800 224 234
Need to chat, call us on 1800 224 234
If you’ve been listening to the industry lately, one thing is clear — the aesthetics landscape is changing.
For years, injectables have been the cornerstone of many cosmetic practices. But as competition increases, regulations tighten, and patient expectations evolve, clinicians across Australia are rethinking their next move.
In a recent episode of the Inside Aesthetics Podcast (Ep 314), Laseraid’s Ashlee Middleton joined Rogen Eulatic from LaForme Clinic Canberra to unpack what this shift really means for practitioners — and how many are already taking action.
The message?
They’re no longer relying solely on filler and toxin treatments to drive revenue. Instead, they’re exploring device-based treatments to diversify, future-proof, and grow their business in a way that’s both sustainable and low-risk.
The feedback is consistent across the board:
This is where Laseraid shines! We’re all about sharing real stories, helpful numbers, and practical solutions that make a difference.
In Episode 314: “From Injecting to Investing”, the discussion dives into how nurses and clinic owners are using flexible access models — rent, rent-to-own, or own — to step confidently into device-led treatments without overextending financially.
Ashlee Middleton breaks down how this model is helping practitioners move from uncertainty to opportunity, while Rogen shares his first-hand experience of scaling from injectables to a fully equipped clinic that delivers skin-first, results-driven treatments.
This is not theory.
It’s the next phase of growth the industry is already embracing.
🎧 Listen Now:
https://open.spotify.com/show/0wBeSRAgm9gvSKLYQnp7Ka
The episode spotlights three of the most in-demand technologies driving clinic growth today:
The gold standard in RF microneedling, bridging the gap between rejuvenation and repair.
The advanced skin health system redefining the client experience.
The skin multitasker tackling pigmentation, texture, and tone.
These devices are not just tools — they’re strategic investments helping clinicians build sustainable, high-performing businesses that go beyond injectables.
This shift isn’t a trend — it’s a transformation. And those who adapt early will lead the next generation of aesthetic success stories.
If you’ve been asking “What’s next for my business?”, this is your sign to find out.
👉 Listen to How to Progress from Injecting to Investing in a device- Episode 314 now and see how the move from injecting to investing is reshaping the future of aesthetics.
Laseraid will be closed from December 22nd to January 8th. For service queries during this time, email service@laseraid.com.au or call 1800 224 234 (select option 2). For general device or account enquiries, email enquiries@laseraid.com.au. We'll get back to you when we return on January 8th.
For online store queries, email orders@laseraid.com.au.
